{"id":701475,"date":"2022-10-26T18:18:24","date_gmt":"2022-10-26T22:18:24","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/"},"modified":"2022-10-26T18:18:24","modified_gmt":"2022-10-26T22:18:24","slug":"vanda-pharmaceuticals-to-announce-third-quarter-2022-financial-results-on-november-2-2022","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/","title":{"rendered":"Vanda Pharmaceuticals to Announce Third Quarter 2022 Financial Results on November 2, 2022"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <b>Conference Call and Webcast to Follow<\/b>\n      <\/p>\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">WASHINGTON<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Oct. 26, 2022<\/span><\/span> \/PRNewswire\/ &#8212; Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the third quarter 2022 on <span class=\"xn-chron\">Wednesday, November 2, 2022<\/span>, after the market closes. \u00a0<\/p>\n<p>Vanda will host a conference call at 4:30 PM ET on <span class=\"xn-chron\">Wednesday, November 2, 2022<\/span>, during which management will discuss the third quarter 2022 financial results and other corporate activities. To participate in the conference call, please dial 1-800-715-9871 (domestic) or 1-646-307-1963 (international) and use passcode 5456289.<\/p>\n<p>The conference call will be broadcast simultaneously and archived on Vanda&#8217;s website, <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3690209-1&amp;h=4155823411&amp;u=http%3A%2F%2Fwww.vandapharma.com%2F&amp;a=www.vandapharma.com\" target=\"_blank\" rel=\"nofollow noopener\">www.vandapharma.com<\/a>. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.<\/p>\n<p>A replay of the call will be available on <span class=\"xn-chron\">Wednesday, November 2, 2022<\/span>, beginning at <span class=\"xn-chron\">8:30 PM ET<\/span> and will be accessible until <span class=\"xn-chron\">Wednesday, November 9, 2022<\/span>, at <span class=\"xn-chron\">8:30 PM ET<\/span>. The replay call-in number is 1-800-770-2030 for domestic callers and 1-609-800-9909 for international callers. The passcode number is 5456289.<\/p>\n<p>\n        <b>About Vanda Pharmaceuticals Inc.<\/b>\n      <\/p>\n<p>Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3690209-1&amp;h=4155823411&amp;u=http%3A%2F%2Fwww.vandapharma.com%2F&amp;a=www.vandapharma.com\" target=\"_blank\" rel=\"nofollow noopener\">www.vandapharma.com<\/a> and follow us on Twitter @vandapharma.<\/p>\n<p>\n        <b><br \/>\n          <u>Corporate Contact: <\/u><br \/>\n        <\/b>\n      <\/p>\n<p>\n        <span class=\"xn-person\">Kevin Moran<\/span><br \/>\n        <br \/>Senior Vice President, Chief Financial Officer and Treasurer\u00a0<br \/>Vanda Pharmaceuticals Inc. <br \/>202-734-3400 <br \/><a href=\"mailto:pr@vandapharma.com\" target=\"_blank\" rel=\"nofollow noopener\">pr@vandapharma.com<\/a>\u00a0<\/p>\n<p>\n        <span class=\"xn-person\">Elizabeth Van Every<\/span><br \/>\n        <br \/>Head of Corporate Affairs <br \/>Vanda Pharmaceuticals Inc. <br \/>202-734-3400 <br \/><a href=\"mailto:pr@vandapharma.com\" target=\"_blank\" rel=\"nofollow noopener\">pr@vandapharma.com<\/a>\u00a0<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=PH16247&amp;sd=2022-10-26\" \/> View original content:<a id=\"PRNURL\" rel=\"nofollow noopener\" href=\"https:\/\/www.prnewswire.com\/news-releases\/vanda-pharmaceuticals-to-announce-third-quarter-2022-financial-results-on-november-2-2022-301660515.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/vanda-pharmaceuticals-to-announce-third-quarter-2022-financial-results-on-november-2-2022-301660515.html<\/a><\/p>\n<p>SOURCE  Vanda Pharmaceuticals Inc.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=PH16247&amp;Transmission_Id=202210261800PR_NEWS_USPR_____PH16247&amp;DateId=20221026\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire Conference Call and Webcast to Follow WASHINGTON , Oct. 26, 2022 \/PRNewswire\/ &#8212; Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the third quarter 2022 on Wednesday, November 2, 2022, after the market closes. \u00a0 Vanda will host a conference call at 4:30 PM ET on Wednesday, November 2, 2022, during which management will discuss the third quarter 2022 financial results and other corporate activities. To participate in the conference call, please dial 1-800-715-9871 (domestic) or 1-646-307-1963 (international) and use passcode 5456289. The conference call will be broadcast simultaneously and archived on Vanda&#8217;s website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Vanda Pharmaceuticals to Announce Third Quarter 2022 Financial Results on November 2, 2022&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-701475","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Vanda Pharmaceuticals to Announce Third Quarter 2022 Financial Results on November 2, 2022 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vanda Pharmaceuticals to Announce Third Quarter 2022 Financial Results on November 2, 2022 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire Conference Call and Webcast to Follow WASHINGTON , Oct. 26, 2022 \/PRNewswire\/ &#8212; Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the third quarter 2022 on Wednesday, November 2, 2022, after the market closes. \u00a0 Vanda will host a conference call at 4:30 PM ET on Wednesday, November 2, 2022, during which management will discuss the third quarter 2022 financial results and other corporate activities. To participate in the conference call, please dial 1-800-715-9871 (domestic) or 1-646-307-1963 (international) and use passcode 5456289. The conference call will be broadcast simultaneously and archived on Vanda&#8217;s website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary &hellip; Continue reading &quot;Vanda Pharmaceuticals to Announce Third Quarter 2022 Financial Results on November 2, 2022&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-26T22:18:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=PH16247&amp;sd=2022-10-26\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-to-announce-third-quarter-2022-financial-results-on-november-2-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-to-announce-third-quarter-2022-financial-results-on-november-2-2022\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Vanda Pharmaceuticals to Announce Third Quarter 2022 Financial Results on November 2, 2022\",\"datePublished\":\"2022-10-26T22:18:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-to-announce-third-quarter-2022-financial-results-on-november-2-2022\\\/\"},\"wordCount\":273,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-to-announce-third-quarter-2022-financial-results-on-november-2-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=PH16247&amp;sd=2022-10-26\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-to-announce-third-quarter-2022-financial-results-on-november-2-2022\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-to-announce-third-quarter-2022-financial-results-on-november-2-2022\\\/\",\"name\":\"Vanda Pharmaceuticals to Announce Third Quarter 2022 Financial Results on November 2, 2022 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-to-announce-third-quarter-2022-financial-results-on-november-2-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-to-announce-third-quarter-2022-financial-results-on-november-2-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=PH16247&amp;sd=2022-10-26\",\"datePublished\":\"2022-10-26T22:18:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-to-announce-third-quarter-2022-financial-results-on-november-2-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-to-announce-third-quarter-2022-financial-results-on-november-2-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-to-announce-third-quarter-2022-financial-results-on-november-2-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=PH16247&amp;sd=2022-10-26\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=PH16247&amp;sd=2022-10-26\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-to-announce-third-quarter-2022-financial-results-on-november-2-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vanda Pharmaceuticals to Announce Third Quarter 2022 Financial Results on November 2, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vanda Pharmaceuticals to Announce Third Quarter 2022 Financial Results on November 2, 2022 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/","og_locale":"en_US","og_type":"article","og_title":"Vanda Pharmaceuticals to Announce Third Quarter 2022 Financial Results on November 2, 2022 - Market Newsdesk","og_description":"PR Newswire Conference Call and Webcast to Follow WASHINGTON , Oct. 26, 2022 \/PRNewswire\/ &#8212; Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the third quarter 2022 on Wednesday, November 2, 2022, after the market closes. \u00a0 Vanda will host a conference call at 4:30 PM ET on Wednesday, November 2, 2022, during which management will discuss the third quarter 2022 financial results and other corporate activities. To participate in the conference call, please dial 1-800-715-9871 (domestic) or 1-646-307-1963 (international) and use passcode 5456289. The conference call will be broadcast simultaneously and archived on Vanda&#8217;s website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary &hellip; Continue reading \"Vanda Pharmaceuticals to Announce Third Quarter 2022 Financial Results on November 2, 2022\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/","og_site_name":"Market Newsdesk","article_published_time":"2022-10-26T22:18:24+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=PH16247&amp;sd=2022-10-26","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Vanda Pharmaceuticals to Announce Third Quarter 2022 Financial Results on November 2, 2022","datePublished":"2022-10-26T22:18:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/"},"wordCount":273,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=PH16247&amp;sd=2022-10-26","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/","name":"Vanda Pharmaceuticals to Announce Third Quarter 2022 Financial Results on November 2, 2022 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=PH16247&amp;sd=2022-10-26","datePublished":"2022-10-26T22:18:24+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=PH16247&amp;sd=2022-10-26","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=PH16247&amp;sd=2022-10-26"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-to-announce-third-quarter-2022-financial-results-on-november-2-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Vanda Pharmaceuticals to Announce Third Quarter 2022 Financial Results on November 2, 2022"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/701475","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=701475"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/701475\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=701475"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=701475"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=701475"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}